TP53 and oropharynx cancer: These data suggest that there is less possibility that E6/E7 oncoproteins control intracellular target genes, including STAT1, through the inhibition of p53 expression in the case of HPV-positive oropharyngeal cancer cells bearing non-disruptive p53 mutation.